Literature DB >> 14751355

Parasagittal biopsies add minimal information in repeat saturation prostate biopsy.

Amit R Patel1, J Stephen Jones, John Rabets, Gerard DeOreo, Craig D Zippe.   

Abstract

OBJECTIVES: To compare the outcome and efficacy of lateral biopsies with parasagittal biopsies in detecting prostate cancer during repeated biopsies performed using the "saturation" technique, which includes 24 cores per biopsy. Prostate biopsy may miss cancer in up to 38% of men eventually found to harbor the disease. Lateral biopsies are more likely than parasagittal biopsies to detect adenocarcinoma according to the findings of several studies.
METHODS: A total of 100 patients, average age 62.1 +/- 7.9 years, underwent repeated transrectal ultrasound-guided saturation biopsy. The study group included 31 patients with previous biopsy results demonstrating high-grade prostatic intraepithelial neoplasia, 7 with atypia, and 62 with benign prostatic tissue but persistently elevated prostate-specific antigen levels. Patients had undergone an average of 1.65 previous biopsies. The average prostate-specific antigen level was 9.4 +/- 6.8 ng/mL. Biopsies were obtained from five sectors on each side and examined histologically.
RESULTS: Cancer was detected in 25 (25%) of the 100 patients. Malignancy was identified in the lateral cores of all patients with positive biopsies. Parasagittal biopsy cores were positive in association with a lateral-based biopsy in 9 (36%) of the 25 malignancies, for an overall parasagittal biopsy core rate of 9% (9 of 100 patients). No cancers were detected in the parasagittal biopsy cores alone.
CONCLUSIONS: Inclusion of parasagittal zone biopsy cores proved to have a low yield in detecting cancer on repeated biopsy. As all patients found to have cancer in the parasagittal biopsy cores also had cancer on the lateral biopsy cores, most time and effort can be spent obtaining lateral biopsy cores to increase the sensitivity on repeated saturation biopsy.

Entities:  

Mesh:

Year:  2004        PMID: 14751355     DOI: 10.1016/j.urology.2003.08.040

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  18 in total

1.  Shared gene expression alterations in prostate cancer and histologically benign prostate from patients with prostate cancer.

Authors:  Farhad Kosari; John C Cheville; Cristiane M Ida; R Jeffrey Karnes; Alexey A Leontovich; Thomas J Sebo; Sibel Erdogan; Erika Rodriguez; Stephen J Murphy; George Vasmatzis
Journal:  Am J Pathol       Date:  2012-05-26       Impact factor: 4.307

Review 2.  When prostate cancer remains undetectable: The dilemma.

Authors:  Mahmoud Othman Mustafa; Louis Pisters
Journal:  Turk J Urol       Date:  2015-03

Review 3.  Advancements in MR imaging of the prostate: from diagnosis to interventions.

Authors:  David Bonekamp; Michael A Jacobs; Riham El-Khouli; Dan Stoianovici; Katarzyna J Macura
Journal:  Radiographics       Date:  2011 May-Jun       Impact factor: 5.333

Review 4.  Management of rising prostate-specific antigen after a negative biopsy.

Authors:  David A Levy; J Stephen Jones
Journal:  Curr Urol Rep       Date:  2011-06       Impact factor: 3.092

Review 5.  Urologic imaging for localized prostate cancer in 2007.

Authors:  Tillmann Loch
Journal:  World J Urol       Date:  2007-03-21       Impact factor: 4.226

6.  [Innovative approaches in prostate cancer ultrasound].

Authors:  T Loch
Journal:  Urologe A       Date:  2006-06       Impact factor: 0.639

Review 7.  Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline.

Authors:  Hossein Jadvar
Journal:  J Nucl Med       Date:  2010-12-13       Impact factor: 10.057

Review 8.  Saturation biopsies for prostate cancer: current uses and future prospects.

Authors:  Nicolas B Delongchamps; Gabriel P Haas
Journal:  Nat Rev Urol       Date:  2009-11-10       Impact factor: 14.432

9.  Optimal prostate biopsy regimen.

Authors:  Ryan K Berglund; J Stephen Jones
Journal:  Curr Urol Rep       Date:  2012-12       Impact factor: 3.092

10.  Saturation biopsies on autopsied prostates for detecting and characterizing prostate cancer.

Authors:  Nicolas B Delongchamps; Gustavo de la Roza; Richard Jones; Mary Jumbelic; Gabriel P Haas
Journal:  BJU Int       Date:  2008-08-01       Impact factor: 5.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.